Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Power wheelchair fraud

This article was originally published in The Gray Sheet

Executive Summary

Senate Finance Committee Chair Charles Grassley (R-Iowa) requests General Accounting Office testimony on Medicare overspending for power wheelchairs. In a Feb. 10 letter to Comptroller General David Walker, Grassley asks GAO to prepare for a possible hearing this spring to review systems in place at CMS and its contractors to identify improper payment for power wheelchairs. CMS recently issued a "clarification" of local coverage policies for power chairs in response to a larger anti-fraud initiative (1"The Gray Sheet" Jan. 5, 2004, p. 3)...

You may also be interested in...



CMS Power Wheelchair LMRP “Clarifications” Denounced By Trade Groups

CMS' interpretation of the term "non-ambulatory" in a recent clarification of local coverage policies for power wheelchairs will significantly restrict beneficiary coverage and access to the DME devices, industry groups argue

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019764

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel